BioCentury
ARTICLE | Company News

Sonus restructures

October 20, 2000 7:00 AM UTC

SNUS began restructuring to refocus on the development of its drug delivery and blood substitute products following last week's withdrawal of an NDA for its EchoGen perflenapent ultrasound contrast ag...